Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit CommitteeCompensation CommitteeNominating and Corporate GovernanceResearch & Development Committee
Charles Cohen, PhD 
Charles Cohen, PhD
Director


Charles Cohen, Ph.D. has been a director since November 1995. Dr. Cohen is an independent investor and the Chief Executive Officer of two biotechnology start-up companies, On Target Therapeutics, LLC and Perform Biologics, Inc. From May 2007 to December 2015, Dr. Cohen was a managing director of Synthesis Capital (formerly Advent Healthcare Ventures), a venture capital firm. Prior to that, Dr. Cohen was Vice President of Advent International, a global private equity firm from 2003 to 2007. From ... 
Committee Member Chairperson   Committee Member
Carl B. Feldbaum 
Carl B. Feldbaum
Director


Carl B. Feldbaum, Esq. has been a director since February 2007. Mr. Feldbaum serves as a member of the board of directors of BIO Ventures for Global Health, a non-profit organization, and is president emeritus of the Biotechnology Industry Organization (BIO), which represents more than 1,000 biotechnology companies, academic institutions and state biotechnology centers internationally. Mr. Feldbaum served as president of BIO from 1993 until his retirement in 2005. Prior to joining BIO, Mr. Feldb... 
  Committee Member Committee Member  
Alan M. Garber, MD, PhD 
Alan M. Garber, MD, PhD
Director


Alan M. Garber, M.D., Ph.D. has been a director since January 2005. He became Provost of Harvard University, Mallinckrodt Professor of Health Care Policy at Harvard Medical School, and a Professor in the Harvard Kennedy School of Government and in the Department of Economics at Harvard in September 2011. Before moving to Harvard, from 1998 until August 2011, he was the Henry J. Kaiser Jr. Professor, a Professor of Medicine, and a Professor (by courtesy) of Economics, Health Research and Policy, ... 
   Chairperson Committee Member
Vincent Marchesi, MD, PhD 
Vincent Marchesi, MD, PhD
Director


Vincent T. Marchesi, M.D., Ph.D. has been a director since May 2001. Since 1973, Dr. Marchesi has been a Professor of Pathology and Cell Biology at Yale University and, since 1991, the Director of the Boyer Center for Molecular Medicine at Yale University. In 1982, Dr. Marchesi co-founded Molecular Diagnostics, Inc., a diagnostic development company. Dr. Marchesi was formerly Chair of Pathology at the Yale-New Haven Hospital. Dr. Marchesi holds an M.D. from Yale University and a Ph.D. from Oxfor... 
  Committee Member   Committee Member
Stelios Papadopoulos, PhD 
Stelios Papadopoulos, PhD
Chairman of the Board, Exelixis, Inc.


Stelios Papadopoulos, Ph.D., a co-founder of Exelixis, has been a director since December 1994 and the Chairman of the Board since January 1998. Dr. Papadopoulos retired as Vice Chairman of Cowen & Co., LLC in August 2006 after six years as an investment banker with the firm, where he focused on the biotechnology and pharmaceutical sectors. Prior to joining Cowen, he spent 13 years as an investment banker at PaineWebber, Incorporated, where he was most recently Chairman of PaineWebber Developmen... 
Committee Member    Committee Member
George Poste, DVM, PhD 
George Poste, DVM, PhD
Director


George Poste, D.V.M., Ph.D., FRS has been a director since August 2004. Since February 2009, Dr. Poste has been the Chief Scientist at Complex Adaptive Systems Initiative and Regents’ Professor and Del E. Webb Professor of Health Innovation at Arizona State University. From May 2003 to February 2009, Dr. Poste served as the director of the Biodesign Institute at Arizona State University. Dr. Poste has served as the Chief Executive Officer of Health Technology Networks, a consulting company that ... 
   Committee Member Chairperson
George A. Scangos, PhD 
George A. Scangos, PhD
Director


George A. Scangos, Ph.D. has been a director since October 1996. Since January 2017, Dr. Scangos has served as Chief Executive Officer and as a member of the board of directors of Vir Biotechnology, Inc., a privately held biotechnology company focused on fighting infectious diseases. From July 2010 to December 2016, Dr. Scangos served as Chief Executive Officer and as a member of the board of directors of Biogen Inc. Prior to joining the Biogen organization, from October 1996 to July 2010, Dr. S... 
    Committee Member
Julie Anne Smith 
Julie Anne Smith
Director


Julie Anne Smith has been a director since September 2016. Since July 2017, Ms. Smith has served as President, Chief Executive Officer and as a member of the board of directors of Nuredis, Inc., a privately-held biotechnology company developing treatments that target the cause of neurological and neuromuscular nucleotide repeat diseases. Prior to Nuredis, she served as President and Chief Executive Officer of Raptor Pharmaceuticals from January 2015 up until the company’s acquisition by Horizon ... 
  Committee Member Committee Member  
Lance Willsey, MD 
Lance Willsey, MD
Director


Lance Willsey, M.D. has been a director since April 1997. Dr. Willsey was a founding partner of DCF Capital, a hedge fund focused on investing in the life sciences, from July 1998 to March 2002, and currently is a consultant to institutional investors in the field of oncology. Since 2000, Dr. Willsey has served on the Visiting Committee of the Department of Genitourinary Oncology at the Dana Farber Cancer Institute at Harvard University School of Medicine. From July 1997 to July 1998, he served ... 
  Committee Member   Committee Member
Jack L. Wyszomierski Financial Expert
Jack L. Wyszomierski
Director


Jack L. Wyszomierski has been a director since February 2004. From June 2004 to June 2009, Mr. Wyszomierski served as the Executive Vice President and Chief Financial Officer of VWR International, LLC, a supplier of laboratory supplies, equipment and supply chain solutions to the global research laboratory industry. From 1982 to 2003, Mr. Wyszomierski held positions of increasing responsibility within the finance group at Schering-Plough Corporation, a health care company, culminating with his a... 
Chairperson   Committee Member